Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Medical treatments of elderly, French patients with type 2 diabetes: results at inclusion in the GERODIAB Cohort.

Doucet JA, Bauduceau B, Le Floch JP, Verny C; SFD/SFGG Intergroup..

Fundam Clin Pharmacol. 2016 Feb;30(1):76-81. doi: 10.1111/fcp.12160. Epub 2015 Nov 8.


Orthostatic hypotension is associated with more severe hypertension in elderly autonomous diabetic patients from the French Gerodiab study at inclusion.

Bouhanick B, Meliani S, Doucet J, Bauduceau B, Verny C, Chamontin B, Le Floch JP; Gerodiab Study Group..

Ann Cardiol Angeiol (Paris). 2014 Jun;63(3):176-82. doi: 10.1016/j.ancard.2014.05.013. Epub 2014 Jun 7.


Cardiovascular events and geriatric scale scores in elderly (70 years old and above) type 2 diabetic patients at inclusion in the GERODIAB cohort.

Bauduceau B, Doucet J, Le Floch JP, Verny C; SFD/SFGG Intergroup and the GERODIAB Group..

Diabetes Care. 2014;37(1):304-11. doi: 10.2337/dc13-1540. Epub 2013 Aug 29.


Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study.

Nørgaard K, Scaramuzza A, Bratina N, Lalić NM, Jarosz-Chobot P, Kocsis G, Jasinskiene E, De Block C, Carrette O, Castañeda J, Cohen O; Interpret Study Group..

Diabetes Technol Ther. 2013 Apr;15(4):273-80. doi: 10.1089/dia.2012.0288. Epub 2013 Feb 25.


GERODIAB: Glycaemic control and 5-year morbidity/mortality of type 2 diabetic patients aged 70 years and older: 1. Description of the population at inclusion.

Doucet J, Le Floch JP, Bauduceau B, Verny C; SFD/SFGG Intergroup..

Diabetes Metab. 2012 Dec;38(6):523-30. doi: 10.1016/j.diabet.2012.07.001. Epub 2012 Oct 10.


Antiphospholipid antibodies as a risk factor for atherosclerotic events in renal transplant recipients.

Ducloux D, Bourrinet E, Motte G, Chalopin JM.

Kidney Int. 2003 Sep;64(3):1065-70.

Supplemental Content

Loading ...
Support Center